Surrozen (SRZN) Treasury Shares (2020 - 2026)

Surrozen (SRZN) posted quarterly Treasury Shares of $811000.0 for Q1 2026, up 4168.42% year-over-year from $19000.0 in Q1 2025, and up 605.22% quarter-over-quarter from $115000.0 in Q4 2025.

Surrozen (SRZN) Treasury Shares (2020 - 2026) Analysis & Trends

Surrozen's Treasury Shares history runs 7 years deep, the most recent figure standing at $811000.0 for Q1 2026.

  • In Q1 2026, Treasury Shares rose 4168.42% year-over-year to $811000.0; the TTM figure through Mar 2026 stood at $811000.0 (up 4168.42% YoY), while the FY2025 annual figure was $115000.0, up 202.63% from the prior year.
  • Treasury Shares for Q1 2026 stood at $811000.0, up from $115000.0 in the prior quarter.
  • The five-year high for Treasury Shares was $811000.0 in Q1 2026, with the low at $130.0 in Q2 2022.
  • The 5-year median for Treasury Shares is $81000.0 (2023), against an average of $104212.8.
  • The sharpest annual moves came in 2022 and 2023: Treasury Shares tumbled 100.0% in 2022, then surged 64934.97% in 2023.
  • Surrozen's Treasury Shares stood at $7000.0 in 2022, then surged by 1185.71% to $90000.0 in 2023, then slumped by 57.78% to $38000.0 in 2024, then surged by 202.63% to $115000.0 in 2025, then jumped by 605.22% to $811000.0 in 2026.
  • Business Quant data shows SRZN's Treasury Shares at $811000.0 in Q1 2026, $115000.0 in Q4 2025, and $115000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 36.40 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 5.08 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 2.72 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 92,219.00
10 Surrozen 281.63 Mn 281.63 Mn - 765,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 765,000.00
Jun 30, 2026 765,000.00
Mar 31, 2026 811,000.00
Mar 31, 2026 811,000.00
Dec 31, 2025 115,000.00
Dec 31, 2025 115,000.00
Sep 30, 2025 115,000.00
Sep 30, 2025 115,000.00
Jun 30, 2025 116,000.00
Jun 30, 2025 116,000.00
Mar 31, 2025 19,000.00
Mar 31, 2025 19,000.00
Dec 31, 2024 38,000.00
Dec 31, 2024 38,000.00
Sep 30, 2024 40,000.00
Sep 30, 2024 40,000.00
Jun 30, 2024 84,000.00
Jun 30, 2024 84,000.00
Mar 31, 2024 44,000.00
Mar 31, 2024 44,000.00